Now Available: GMP-grade Modified NTPs

Industry-leading Modified NTPs for mRNA production

TriLink’s high-purity modified nucleoside triphosphates (NTPs) optimize and enhance mRNA performance to promote robust expression. From research use to the first-ever GMP-grade offering, TriLink provides a portfolio of off-the-shelf, chemically synthesized NTPs that are ready to scale to your unique production needs.

A Cut Above the Rest

As one of the first manufacturers of N1‑Methylpseudouridine-5’-Triphosphate, TriLink provides some of the best NTPs on the market with several benefits for improved mRNA vaccine and therapeutic production.

  • GMP Grade Available (the first on the market!)
  • Portfolio of Off-the-Shelf Solutions
  • Increased Translation Efficiency
  • Reduces Immunogenicity

Proven Performance

From North America to the Asia-Pacific, our NTPs are foundational components in various vaccine programs across the globe. Our trusted modified NTPs, including N1-Methylpseudouridine-5’-Triphosphate, are the proven ideal compounds for mRNA synthesis.

Request a Quote for
Modified NTPs

Request a Quote for Modified NTPs

MT-943 - Form for page(s): request-a-gmp-reagents-consultation


Request a Quote for Modified NTPs

quality-standard

The Highest Quality Standards

TriLink operates an ISO 9001:2015 facility that helps ensure our chemically synthesized production materials for mRNA meet reported requirements for identity, quality, and purity. Our stringent quality systems and a dedicated team of quality experts ensure the highest level of consistency, purity, and comprehensive documentation.

Modified Uridines for Every Stage

Whether you require research use or GMP grade, TriLink offers over 150 modified nucleoside triphosphates to meet diverse application needs.

NTP Brochure Download

General
TriLink BioTechnologies does not sell or distribute your information to 3rd parties. For more information, please refer to our Privacy Policy.

""